CORRESP Filing
IceCure Medical Ltd.
Date: July 3, 2025 · CIK: 0001584371 · Accession: 0001213900-25-061369
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288062
Letter
IceCure Medical Ltd.
7 Ha'Eshel St., PO Box 3163
Caesarea, 3079504 Israel
July 3, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE: IceCure Medical Ltd. (CIK 0001584371)
Registration Statement No. 333-288062 on Form F-1 (the "Registration Statement")
Ladies and Gentlemen:
IceCure Medical Ltd. (the " Registrant ") hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the " Securities Act "), so that it may become effective on July 9, 2025 at 5:15 p.m., Eastern Time, or as soon thereafter as is practicable.
The Registrant understands that the Commission will consider this request for acceleration of the effective date of the Registration Statement as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act as they relate to the proposed public offering of the securities specified in the Registration Statement.
The Registrant respectfully requests that it be notified of such effectiveness by a telephone call to Eric Victorson, Esq. of Sullivan & Worcester LLP at (212) 660 3092 and that such effectiveness also be confirmed in writing.
Very truly yours,
IceCure Medical Ltd.
Show Raw Text
CORRESP 1 filename1.htm IceCure Medical Ltd. 7 Ha'Eshel St., PO Box 3163 Caesarea, 3079504 Israel July 3, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 RE: IceCure Medical Ltd. (CIK 0001584371) Registration Statement No. 333-288062 on Form F-1 (the "Registration Statement") Ladies and Gentlemen: IceCure Medical Ltd. (the " Registrant ") hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the " Securities Act "), so that it may become effective on July 9, 2025 at 5:15 p.m., Eastern Time, or as soon thereafter as is practicable. The Registrant understands that the Commission will consider this request for acceleration of the effective date of the Registration Statement as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act as they relate to the proposed public offering of the securities specified in the Registration Statement. The Registrant respectfully requests that it be notified of such effectiveness by a telephone call to Eric Victorson, Esq. of Sullivan & Worcester LLP at (212) 660 3092 and that such effectiveness also be confirmed in writing. Very truly yours, IceCure Medical Ltd. By: /s/ Ronen Tsimerman Ronen Tsimerman, Chief Financial Officer